INTRODUCTION
In 2012, an estimated 52,610 individuals in the United States will be diagnosed with head and neck cancer and approximately 11,500 Americans are expected to die from a head and neck cancer. 1 Cancers of the head and neck include a diverse group of malignant neoplasms that are grouped together due to similarities in pattern of spread, staging, and treatments. 2 Disease-related and treatment-related morbidity and symptom burden can have deleterious effects upon mood, sleep quality, physical function, and social function. [2] [3] [4] [5] [6] [7] [8] [9] Physical side effects from treatment (surgery, radiation, and/or chemotherapy) include voice loss, difficulty eating, taste changes, difficulty swallowing, difficulty breathing, fatigue, pain, and disfigurement. [8] [9] [10] [11] Depression is common among patients with head and neck cancer even before the start of treatment and increases during treatment. 2, 9, [12] [13] [14] Some studies have found 40% to 46% of patients have screened positive for depressive symptoms. 13, 14 Sleep disturbances are also common. 15 Together, the symptom burden, poor mental health, and decreased functioning (ie, communication, eating, breathing, sleep, and socialization) all have a negative effect on quality of life, especially in the area of social wellbeing. 8, 9 Inability to communicate or to share meals at restaurants with friends and family members can further have a negative impact on mental health.
The burden of head and neck cancer is particularly great on African Americans. [16] [17] [18] Compared with non-Hispanic whites, African Americans tend to be diagnosed with head and neck cancer at a younger age, at a more advanced stage, and with reduced survival probability. 17, 18 In addition, some studies have found that African Americans are undertreated for cancer relative to nonHispanic whites. 19 As a result, African Americans have greater morbidity and mortality due to head and neck cancer than other races/ethnicities. [16] [17] [18] To the best of our knowledge, there are no large population-based studies evaluating differences in health-related quality of life (HRQOL) between African Americans and non-Hispanic whites with head and neck cancers.
To address this critical knowledge gap, a HRQOL study was incorporated into the Carolina Head and Neck Cancer Epidemiology (CHANCE) study. The CHANCE study is one of the largest population-based molecular epidemiology studies of head and neck cancer (oral, pharyngeal, and laryngeal) conducted in the United States to date, with 1396 patients participating from across North Carolina. In studying the experiences of head and neck cancer survivors and disparities in HRQOL among African Americans, the goal is to help health care professionals more effectively manage the impact of treatment on patients' quality of life. Given the health disparities reported for African Americans in terms of disease stage and survival rates, it was expected that African Americans would report poorer HRQOL than non-Hispanic whites. In addition, lower income African Americans would disproportionally be affected, as low socioeconomic status (SES) has been related to poorer access to health care and poorer HRQOL. [20] [21] [22] This hypothesis is consistent with the Behavioral Model for Vulnerable Populations, which suggests that both race/ethnicity and SES impact health status. 23, 24 
MATERIALS AND METHODS

Participants
The CHANCE study included patients, aged 20 to 80, who were residents of a 46-county region in North Carolina, with a newly diagnosed first primary invasive squamous cell carcinoma between January 1, 2002 and February 28, 2006 . 25 This study was approved by the institutional review board of the University of North Carolina at Chapel Hill. Patients were excluded if they had tumors of the lip, salivary glands, nasopharynx, nasal cavity, and nasal sinuses. Individuals with carcinomas of other histologies, carcinomas at other head and neck sites, or a history of recurrent or second primary tumors were also not eligible. Using rapid case ascertainment conducted through the North Carolina Central Cancer Registry, newly diagnosed cancer cases were identified and reported to the study office every month. Pathology reports and corresponding slides of tumor specimens from the patient's diagnostic surgery were obtained and histologic confirmation was verified by the study pathologist.
After physician notification, potentially eligible participants (able to read/write English, cognitively able to selfreport) were first contacted by mail and then by nurseinterviewers to verify eligibility and schedule a baseline interview. Written informed consent was obtained from the patients before the interview. From the baseline interview process, permission to obtain medical records was obtained. The medical records were collected and abstracted in order to obtain comprehensive information on each patient's first course of treatment (usually within 6 months of initial diagnosis) and information on pertinent comorbid conditions.
Measures
The HRQOL assessment was incorporated in the CHANCE protocol in 2005 among a subcohort of 267 patients invited to participate. The in-person interview collected data on individuals' sociodemographic characteristics including age (less than 50, 50-64, 65-74, and 75 or more years), sex (male or female), race (African American or non-Hispanic white), education (high school graduate or less, some college, or college degree or higher), marital status (living alone, living with spouse, or significant other), and insurance status (none, private, government, or multiple insurance types). Participants reported their health behaviors as they relate to tobacco use (never, former, recently quit, or current smoker) and alcohol use (never, former, recently quit, or current drinker). Individuals also reported their height and weight (for calculating body mass index [BMI] ; categorized as underweight/normal, overweight, or obese) and comorbid conditions including anemia, liver disease, hepatitis, cardiovascular disease, pulmonary disease, renal disease, diabetes, and cancers other than head and neck. The comorbid conditions variable was categorized as no versus 1 or more chronic conditions. Patients also selfreported the type of treatment they received (eg, surgery, radiation, or chemotherapy) and if they were currently using a feeding tube.
For HRQOL, individuals completed the Functional Assessment of Cancer Therapy -Head and Neck (FACT-H&N) questionnaire. 26, 27 The FACT-H&N included the FACT-general, which assesses physical well-being (7 questions; score range, 0-28; minimally important difference [MID] ¼ 2-3 points), social/family well-being (7 questions; score range, 0-28; MID not available), emotional well-being (6 questions; score range, 0-24; MID ¼ 2 points), and functional well-being (7 questions; score range, 0-28; MID ¼ 2-3 points). 28, 29 The FACT-H&N includes 12 additional questions on symptoms and issues specific to head and neck cancers including ability to eat, dry mouth, difficulty breathing, difficulty swallowing, voice quality, ability to communicate, body image, pain in the mouth, throat, or neck, and alcohol and tobacco use. Following the FACT-H&N scoring guidelines, we summed across 9 of the 12 questions in the FACT-H&N (excluding alcohol and tobacco use, and pain) to create the Head and Neck Cancer Subscale (HNCS) score (score range, 0-36; MID ¼ 3-4 points). All items on the FACT-H&N use a 7-day reference period and include 5 response options: "not at all," "a little bit," "somewhat," "quite a bit," and "very much." High scores on all scales of the FACT-H&N represent better HRQOL. 29 MIDs are defined as the smallest difference in scores between groups that patients perceive as important or personally meaningful, either beneficial or harmful. 29, 30 Reliability (internal consistency) for 3 of the FACT-H&N subscales was satisfactory for group comparisons: physical well-being ¼ 0.87, social well-being ¼ 0.75, and functional well-being ¼ 0.88. However, reliability was insufficient (ie, below 0.70) for emotional well-being (r ¼ 0.62) and the HNCS (r ¼ 0.49). Subscale reliabilities by race were similar to the reliabilities with the groups combined.
The HRQOL data collection was conducted between April 18, 2005, and December 19, 2005 . FACT-H&N questionnaires were mailed to 267 cancer survivors within approximately 1 year after diagnosis. The total number of questionnaires obtained during this period was 233. The response rate was excellent: 87.3% overall, 84.9% among African-Americans, and 89.5% among whites. After eliminating 6 ineligible patients and 5 with extensive missing data, HRQOL and other data were available for a total of 222 patients (54 African Americans and 168 non-Hispanic whites). The sample (n ¼ 222) with baseline HRQOL data did not significantly differ from the rest of the total cohort on the basis of stage, tumor site, type of treatment, age, sex, and race.
Clinical data were abstracted from the patients' medical records including tumor site (oral, laryngeal, or pharyngeal), stage (I, II, III, or IV), time from diagnosis to HRQOL questionnaire administration (0 to 6 months, >6 to 12 months, or >12 months), lymph node involvement ("yes" or "no"), and angiolymphatic invasion ("yes" or "no").
Data analyses
Demographic and clinical characteristics were summarized within each race group and overall. Comparisons of proportions between the 2 race groups were based on chi-square test at 0.05 significance levels. Analysis of variance or t tests were used to compare the unadjusted means on the FACT HRQOL subscales between the 2 race groups. Linear regression models were used to model each of the FACT HRQOL subscales regressed on demographic and clinical characteristics. To identify factors that are related to the FACT HRQOL subscales, backward variable selection procedures were used. The initial full model contained all variables listed in the first column of Table 1 and the interaction between race and income. Because of the large number of candidate variables (22) and relatively limited sample size (n ¼ 222), we used 0.10 significance level for the deletion criterion. Race was forced in the model regardless of whether it was statistically significant, because it was the primary focus for this study. The variable selection procedure kept the hierarchical structure of the model such that the model would include both the main effects for race and income if the interaction between them was statistically significant. In addition to the terms related to race and income, the final model only included the variables significantly associated with the FACT HRQOL subscale. Adjusted means and the associated SE are presented for the final model. The adjusted means for different levels of a factor are evaluated at the mean level of the other variables in the model. Because all the covariates are categorical, the mean of a variable is equivalent to the proportion of that category in the sample. Analyses were performed using GLMSELECT and GLM procedures in SAS software, v 9.2.
With the current study sample size of 54 African Americans and 168 non-Hispanic whites and at the 0.05 significance level, power for the study was 38%, 49%, and 79% to detect an MID of 2 points for the functional well-being, physical well-being, and emotional well-being subscales, respectively; and power was 61% to detect an MID of 3 points for the HNCS. Table 1 provides a summary of the demographic and clinical characteristics for the 222 participants in the study stratified by race, including African Americans (n ¼ 54) and non-Hispanic whites (n ¼ 168). Compared with non-Hispanic whites, African Americans were poorer (70% with income less than $20,000 compared to 26% of whites), less educated (78% with a high school diploma or less compared to 54% of whites), living alone (59% alone compared to 31% of whites), receiving insurance through Medicare or Medicaid (61% compared to 32% of whites), and smoked in their lifetime (98% compared to 79% of whites). African Americans were marginally more likely (p ¼ .0541) than non-Hispanic whites to have been diagnosed with laryngeal cancer (46% vs 32%, respectively), and less likely to have oral cancer (39% vs 58%, respectively). On average, the time from diagnosis to the survey ranged from 1 to 43 months with the average time since diagnosis approximately 4.8 months (4.5 months for African Americans and 4.9 months for non-Hispanic whites).
RESULTS
Unadjusted mean scores and SDs for each of the FACT subscales (physical well-being, emotional well-being, social well-being, functional well-being, and head and neck concerns) are provided in Table 2 . For each outcome (ie, FACT subscale), Table 3 includes the adjusted means and SEs controlling for each variable that remained in the model after using backward regression selection methods.
Functional Assessment Cancer Therapy physical well-being subscale
African Americans had statistically significantly higher (better) physical well-being scores than non-Hispanic whites, with adjusted physical well-being means of 23.1 and 20.9, respectively (Table 3) . This difference exceeds the MID for the physical well-being subscale. Poorer physical well-being for those with head and neck cancer was associated with having 4 or more individuals in the household, younger age, lower education, government insurance, current smoker or recently quit smoking, diagnosed with cancer within 6 months from survey, having a feeding tube, and having received radiation treatment.
Functional Assessment Cancer Therapy emotional well-being subscale
There was a significant race-by-income interaction for emotional well-being. Low income non-Hispanic whites reported the poorest emotional well-being (adjusted mean ¼ 17.3). In contrast, low-income African Americans reported the highest emotional well-being (adjusted mean ¼ 21.4) relative to the other groups. This difference exceeds the MID for the subscale. In addition, poorer emotional well-being was found to be statistically significantly related to current smoker, having 1 or more comorbid conditions, and having laryngeal or pharyngeal cancer.
Functional Assessment Cancer Therapy social/family well-being subscale
There was no significant relationship between race and social well-being. Poorer social well-being was associated with lower income, living alone, current alcohol use, having 1 or more comorbid conditions, having laryngeal cancer, and having stage III or IV cancer.
Functional Assessment Cancer Therapy functional well-being subscale
There was no significant relationship between race and functional well-being. Worse functioning was statistically significantly associated with having 4 or more individuals in the household, having no insurance, being a current smoker, having 1 or more comorbid conditions, having stage III cancer, within 6 months from cancer diagnosis, having a feeding tube, and having received radiation treatment.
Functional Assessment Cancer Therapy head and neck cancer subscale
There was a significant race-by-income interaction for head and neck concerns. African Americans with income greater than $20,000 reported the most problematic symptoms and concerns associated with head and neck cancer (adjusted mean ¼ 18.7). Lower-income African Americans reported fewer problems (adjusted mean ¼ 22.0) relatively. This difference exceeds the MID for the subscale. In addition, more head and neck concerns were associated with having 4 or more individuals in the household, lower education levels, having 1 or more comorbid conditions, having stage III or IV cancer, having a feeding tube, and having received radiation treatment.
Health-related quality of life differences by race for individuals within 6 months from diagnosis Because approximately 86% of the patients with cancer were within 6 months from diagnosis, we performed a sensitivity analysis to see if the race effects we observed in the full sample for the HRQOL outcomes differed if we excluded those who completed the HRQOL questionnaire greater than 6 months from diagnosis. The findings restricted to those within 6 months from diagnosis were consistent with the full sample for the domains of physical well-being (p ¼ .03) and emotional well-being (p ¼ .01 for race-by-income interaction; p ¼ .02 for race main effect). However, for those whose cancer diagnosis was within 6 months, there was no significant interaction between race and income for the FACT HNCS (p ¼ .17). For these individuals, being in radiation treatment (p < .01) was associated with more head and neck cancer-specific concerns and symptoms.
DISCUSSION
This is one of the first population-based studies to examine differences in HRQOL between African Americans and non-Hispanic whites in North Carolina who have a head and neck cancer. With an average of 5 months from diagnosis to survey, African Americans reported better physical well-being than non-Hispanic whites at a magnitude that exceeds what is considered the MID estimate. These differences remained even when limiting the sample to individuals within 6 months from diagnosis. There were no race differences for social or functional well-being. A more complex race-by-income interaction was observed for emotional well-being and for head and neck cancer-specific concerns and symptoms.
There are a number of underlying factors that may account for the differences in HRQOL experiences among African Americans and non-Hispanic whites with head and neck cancer. Tobacco and alcohol use are primary risk factors associated with the development of head and neck cancer. [31] [32] [33] [34] [35] [36] [37] They are also behavioral factors associated with poorer HRQOL. 38, 39 In our cohort, only 2% of African Americans never smoked, compared to approximately 21% of non-Hispanic whites who never smoked. At the time of the survey, we found equal percentages (26%) of current smokers; however, 46% of African Americans recently quit smoking since being diagnosed with cancer, relative to 22% of non-Hispanic whites. We included history of tobacco use as a covariate and, thus, differences in other factors were adjusted for tobacco use.
A similar trend was observed with alcohol use; however, it was not significantly different between the 2 groups. Approximately 4% of African Americans never drank alcohol compared to 13% of non-Hispanic whites. African Americans reported slightly lower levels of current drinking relative to whites (20% vs 26%, respectively); however, a greater percentage of African Americans recently quit drinking than non-Hispanic whites (37% vs 26%, respectively).
Lower SES also is a major risk factor for head and neck cancer as well as it is associated with poorer HRQOL. Individuals with low SES often have no or inadequate health insurance and poorer access to healthcare. 40 Low SES can have a significant effect on HRQOL. 41, 42 A number of studies have found a significant number of patients with head and neck cancer who became disabled after cancer diagnosis, ranging from 33% to 52%, 21, 43, 44 impacting their ability to work and, thus, lowering their SES. In our sample of individuals with head and neck cancer in North Carolina, African Americans had disproportionally lower income levels (70% of African Americans with income below $20,000 relative to 26% of non-Hispanic whites) and lower education levels (78% of African Americans only had a high school education or less relative to 54% of non-Hispanic whites). Further, health insurance coverage varied by race. African Americans reported 17% with private insurance (49% for whites), and 61% with government insurance (32% for whites), and 15% of African Americans reported no health insurance relative to 9% for whites. We found 2 significant income-by-race interactions in this study. African Americans with income greater than $20,000 reported the most problems associated with head and neck cancer concerns and symptoms (eg, difficulty eating, voice quality, unhappy with appearance of face and neck). In contrast, lower income African Americans reported the least concerns and symptoms relative to the other groups. However, the income-by-race interaction was not significant when limiting the sample to individuals within 6 months from diagnosis. The other significant interaction was that lower income African Americans reported better emotional well-being compared with other groups, whereas lower income non-Hispanic whites reported the poorest emotional well-being. These differences exceeded the MID estimates emphasizing their clinical importance. Also, the interaction remained even after limiting the sample to individuals within 6 months from diagnosis.
There are few studies in cancer that have examined HRQOL differences by race. 45 In a sample of 1428 patients with cancer (80% had head and neck cancer) participating in Radiation Therapy Oncology Group trials, Movsas et al 45 found no statistically significant differences in physical, social, or emotional well-being scores between African Americans and whites. In a study by Rao et al 46 among 502 African Americans and 396 nonHispanic whites with AIDS-related malignancies or breast, colon, head and neck (28 whites, 45 African Americans), and lung cancer, African Americans reported poorer physical and social well-being but better emotional well-being than non-Hispanic whites. Better coping strategies, close-knit friends and family, and spirituality were speculated, but not empirically tested, to contribute to better emotional well-being for African Americans. 16, 46, 47 Beyond the cancer literature, epidemiologic studies have found that, compared to non-Hispanic whites, African Americans have lower rates of mental health disorders even after controlling for SES, despite poorer physical health. [48] [49] [50] [51] According to one theory for this finding by Jackson et al, 52 African Americans engage in more poor health behaviors (eg, smoking and alcohol use) because they are the most accessible coping strategies for disadvantaged groups. 51, 52, 53 These behaviors act on common biologic structures and process associated with pleasure and reward systems; thus alleviating stress. 51, [54] [55] [56] [57] Although we cannot confirm this theory, it does provide one possible explanation for our finding of better mental well-being among African Americans compared with non-Hispanic whites.
One of the strengths of this study is that the FACT instruments have been extensively used in other cancer studies in the United States. Table 4 compares the unadjusted mean scores for the African Americans and nonHispanic whites in the present study with the general US population means and with other published head and neck cancer studies. Because we do not have access to the data from these other sources, we cannot perform formal statistical testing; however, we observe differences between our study and other studies based on the magnitude of differences between study results compared to published MIDs on the FACT subscales. 29 Compared to the US general population, the African Americans and non-Hispanic whites seem to have similar levels of physical wellbeing and emotional well-being, better social well-being, but decreased functional well-being. 29 Lack of differences between the US general population and the individuals with head and neck cancer may be partially explained by a response shift; that is, patients with cancer may experience a recalibration of what physical well-being (eg, pain and fatigue) and emotional well-being (eg, depressive mood and anxiety) means to them and how they may be affected by it. [58] [59] [60] [61] This cross-sectional study cannot empirically evaluate this cognitive process.
The HRQOL of individuals with head and neck cancer observed in this study were relatively comparable to patients in other published studies with patients with head and neck cancer, but there were some differences noted below. The original validation study of the FACT-H&N (List et al 27 ) included 151 patients who were receiving or had completed treatment (63%) and included African Americans (31%). Compared to the List et al 27 study, the participants in this current study seem to have better emotional well-being, but worse functional well-being. The Pandey et al 2 study included 123 patients with head and neck undergoing active treatment. Physical well-being seems to be worse, but functional well-being seems to be better for individuals in the Pandey et al 2 study relative to the individuals in the current study. Rogers et al 3 evaluated HRQOL in 65 patients with head and neck cancer approximately 6 months from diagnosis and off treatment. The individuals in the Rogers et al 3 study seem to have worse social well-being but better functional well-being than the individuals in the current study. Both the Pandey et al 2 and the Rogers et al 3 studies used a different number of items to calculate the HNCS scores from this study; thus, we could not compare their HNCS scores with ours.
This study had several limitations. The HRQOL study was added on after the parent study had begun, thus, resulting in lower sample sizes. Therefore, power for many of our comparisons was reduced, impacting SE estimates. This limited our ability to fully explore differences by race for each tumor site or for different treatment modalities. The survey was done after diagnosis and baseline prediagnosis HRQOL data were not available; thus, we could not look at changes in HRQOL before or at diagnosis. Also, the reliability for the FACT emotional well-being and the HNCS were not sufficient for group level measurement indicating the measure was not precise for differentiating among our groups; however, we were able to still detect racial differences on these subscales. Further, we could not include a control group (ie, those without cancer) to help us disentangle what may be underlying causes of lower HRQOL in respect to background variables such as SES. Last, the samples are limited to patients residing in North Carolina; thus, we cannot generalize results to other regions of the country. Together, it is important for future research to replicate the findings observed in this study and to look more in depth at race and SES differences by specific cancer sites and types and phases of treatment.
Despite its limitations, this study advances our knowledge of the effects of head and neck cancer and its treatment on the lives of African Americans. The study sample was based on a large population-based study with a collection of covariates and medical history data. This study found that social and functional well-being was similar between African Americans and non-Hispanic whites; however, there was a race-by-income level interaction for emotional well-being and head and neck cancer symptoms. Surprisingly, low-income African Americans reported better HRQOL on these 2 outcomes relative to the other groups. Further, African Americans reported better physical well-being than non-Hispanic whites. Underlying reasons for this finding will have to be explored in further studies. It is hoped that future studies of the HRQOL of individuals with head and neck cancer will consider oversampling underserved populations (eg, African Americans, Hispanics, and low income) to allow us to better understand the health disparities among these populations and look for opportunities to provide better psychosocial support services to improve their care.
